Inflammopharmacology

, Volume 21, Issue 6, pp 389–396 | Cite as

Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management

  • Donald W. Howie
  • Susan D. Neale
  • David R. Haynes
  • Oksana T. Holubowycz
  • Margaret A. McGee
  • Lucian B. Solomon
  • Stuart A. Callary
  • Gerald J. Atkins
  • David M. Findlay
Review

Abstract

Periprosthetic osteolysis is a serious complication of total hip replacement (THR) in the medium to long term. Although often asymptomatic, osteolysis can lead to prosthesis loosening and periprosthetic fracture. These complications cause significant morbidity and require complex revision surgery. Here, we review advances in our understanding of the cell and tissue response to particles produced by wear of the articular and non-articular surfaces of prostheses. We discuss the molecular and cellular regulators of osteoclast formation and bone resorptive activity, a better understanding of which may lead to pharmacological treatments for periprosthetic osteolysis. We describe the development of imaging techniques for the detection and measurement of osteolysis around THR prostheses, which enable improved clinical management of patients, provide a means of evaluating outcomes of non-surgical treatments for periprosthetic osteolysis, and assist in pre-operative planning for revision surgery. Finally, there have been advances in the materials used for bearing surfaces to minimise wear, and we review the literature regarding the performance of these new materials to date.

Keywords

Periprosthetic Osteolysis Clinical management Barrie Vernon-Roberts 

Notes

Acknowledgments

The authors acknowledge the profound influence of Professor Barrie Vernon-Roberts on the elucidation of the cause of periprosthetic osteolysis, and on their own research careers and research directions. His remarkable powers of observation, important mentoring activities and scientific insights, support and encouragement have directly and indirectly benefited us all greatly. We thank Dr. Roumen Stamenkov for his contributions to the work. We acknowledge the support of the Australian National Health and Medical Research Council (NHMRC), the Australian Orthopaedic Association Research Foundation, the Royal Adelaide Hospital, the University of Adelaide and the medical and nursing staff of the Royal Adelaide Hospital.

References

  1. Alias E, Dharmapatni AS, Holding AC, Atkins GJ, Findlay DM, Howie DW, Crotti TN, Haynes DR (2012) Polyethylene particles stimulate expression of ITAM-related molecules in peri-implant tissues and when stimulating osteoclastogenesis in vitro. Acta Biomater 8:3104–3112PubMedCrossRefGoogle Scholar
  2. Arabmotlagh M, Pilz M, Warzecha J, Rauschmann M (2009) Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty. J Orthop Res 27:183–188PubMedCrossRefGoogle Scholar
  3. Asagiri M, Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40:251–264PubMedCrossRefGoogle Scholar
  4. Atkins GJ, Findlay DM (2012) Osteocyte regulation of bone mineral: a little give and take. Osteoporos Int 23:2067–2079PubMedCrossRefGoogle Scholar
  5. Atkins GJ, Welldon KJ, Holding CA, Haynes DR, Howie DW, Findlay DM (2009) The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles. Biomaterials 30:3672–3681PubMedCrossRefGoogle Scholar
  6. Bradford L, Baker DA, Graham J, Chawan A, Ries MD, Pruitt LA (2004) Wear and surface cracking in early retrieved highly cross-linked polyethylene acetabular liners. J Bone Joint Surg Am 86:1271–1282PubMedGoogle Scholar
  7. Chiang PP, Burke DW, Freiberg AA, Rubash HE (2003) Osteolysis of the pelvis. Evaluation and treatment. Clin Orthop Relat Res 417:164–174PubMedGoogle Scholar
  8. Crotti TN, Smith MD, Findlay DM, Zreiqat H, Ahern MJ, Weedon H, Hatzinikolous G, Capone M, Holding C, Haynes DR (2004) Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. Biomaterials 25:565–573PubMedCrossRefGoogle Scholar
  9. Endo M, Tipper JL, Barton DC, Stone MH, Ingham E, Fisher J (2002) Comparison of wear, wear debris and functional biological activity of moderately crosslinked and non-crosslinked polyethylenes in hip prostheses. **Proc Instn Mech Engrs Part H 216:111–122CrossRefGoogle Scholar
  10. Engh AC Jr, Sychterz CJ, Young AM, Pollock DC, Toomey SD, Engh CA Sr (2002) Interobserver and intraobserver variability in radiographic assessment of osteolysis. J Arthroplasty 17:752–759PubMedCrossRefGoogle Scholar
  11. Engh CA Jr, Egawa H, Beykirch SE, Hopper RH, Engh CA (2007) The quality of osteolysis grafting with cementless acetabular component retention. Clin Orthop Relat Res 465:150–154PubMedGoogle Scholar
  12. Engh CA Jr, Hopper RH Jr, Huynh C, Ho H, Sritulanondha S, Engh CA Sr (2012) A prospective, randomized study of cross-linked and non cross-linked polyethylene for total hip arthroplasty at 10-year follow-up. J Arthroplasty 27:2–7PubMedCrossRefGoogle Scholar
  13. Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ (2002) TNFα potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143:1108–1118PubMedCrossRefGoogle Scholar
  14. Garcia-Cimbrelo E, Tapia M, Martin-Hervas C (2007) Multislice computed tomography for evaluating acetabular defects in revision THA. Clin Orthop Relat Res 463:138–143PubMedGoogle Scholar
  15. Gehrke T, Sers C, Morawietz L, Fernahl G, Neidel J, Frommelt L, Krenn V (2003) Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening. Scand J Rheumatol 32:287–294PubMedCrossRefGoogle Scholar
  16. Goater JJ, O’Keefe RJ, Rosier RN, Puzas JE, Schwarz EM (2002) Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 20:169–173PubMedCrossRefGoogle Scholar
  17. Green TR, Fisher J, Stone M, Wroblewski BM, Ingham E (1998) Polyethylene particles of a “critical size” are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 19:2297–2302PubMedCrossRefGoogle Scholar
  18. Harris WH (1995) The problem is osteolysis. Clin Orthop Relat Res 311:46–53PubMedGoogle Scholar
  19. Haynes DR, Rogers SD, Hay S, Pearcy MJ, Howie DW (1993) The differences in toxicity and release of bone-resorbing mediators induced by titanium and cobalt-chromium-alloy wear particles. J Bone Joint Surg Am 75:825–834PubMedGoogle Scholar
  20. Haynes DR, Crotti TN, Potter AE, Loric M, Atkins GJ, Howie DW, Findlay DM (2001) The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg Br 83:902–911PubMedCrossRefGoogle Scholar
  21. Haynes DR, Crotti TN, Zreiqat H (2004) Regulation of osteoclast activity in peri-implant tissues. Biomaterials 25:4877–4885PubMedCrossRefGoogle Scholar
  22. Holding CA, Findlay DM, Stamenkov R, Neale SD, Lucas H, Dharmapatni AS, Callary SA, Shrestha KR, Atkins GJ, Howie DW, Haynes DR (2006) The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants. Biomaterials 27:5212–5219PubMedCrossRefGoogle Scholar
  23. Howie DW (1990) Tissue response in relation to type of wear particles around failed hip arthroplasties. J Arthroplasty 5:337–348PubMedCrossRefGoogle Scholar
  24. Howie DW, Vernon-Roberts B (1988a) The synovial response to intraarticular cobalt-chrome wear particles. Clin Orthop Relat Res 232:244–254PubMedGoogle Scholar
  25. Howie DW, Vernon-Roberts B (1988b) Long term effects of intraarticular cobalt-chrome alloy wear particles in rats. J Arthroplasty 3:327–336PubMedCrossRefGoogle Scholar
  26. Howie DW, Vernon-Roberts B, Oakeshott R, Manthey B (1988) A rat model of resorption of bone at the cement-bone interface in the presence of polyethylene wear particles. J Bone Joint Surg Am 70:257–263PubMedGoogle Scholar
  27. Howie DW, Cornish BL, Vernon-Roberts B (1990) Resurfacing hip arthroplasty: classification of loosening and the role of prosthesis wear particles. Clin Orthop Relat Res 255:144–159PubMedGoogle Scholar
  28. Howie DW, Manthey B, Hay S, Vernon-Roberts B (1993) The synovial response to intraarticular injection in rats of polyethylene wear particles. Clin Orthop Relat Res 292:352–357PubMedGoogle Scholar
  29. Howie DW, Neale SD, Stamenkov R, McGee MA, Taylor DJ, Findlay DM (2007) Progression of acetabular periprosthetic osteolytic lesions measured by computed tomography. J Bone Joint Surg Am 89:1818–1825PubMedCrossRefGoogle Scholar
  30. Howie DW, Neale SD, Martin W, Costi K, Kane T, Stamenkov R, Findlay DM (2012) Progression of periacetabular osteolytic lesions. J Bone Joint Surg Am 94:e1171–e1176PubMedGoogle Scholar
  31. Illgen RL 2nd, Bauer LM, Hotujec BT, Kolpin SE, Bakhtiar A, Forsythe TM (2009) Highly crosslinked vs conventional polyethylene particles: relative in vivo inflammatory response. J Arthroplasty 24:117–124PubMedCrossRefGoogle Scholar
  32. Ingram JH, Stone M, Fisher J, Ingham E (2004) The influence of molecular weight, crosslinking and counterface roughness on TNF-alpha production by macrophages in response to ultra high molecular weight polyethylene particles. Biomaterials 25:3511–3522PubMedCrossRefGoogle Scholar
  33. Jiranek WA, Machado M, Jasty M, Jevsevar D, Wolfe HJ, Goldring SR, Goldberg MJ, Harris WH (1993) Production of cytokines around loosened cemented acetabular components. J Bone Joint Surg Am 75:863–884PubMedGoogle Scholar
  34. Kitamura N, Leung SB, Engh CA Sr (2005) Characteristics of pelvic osteolysis on computed tomography after total hip arthroplasty. Clin Orthop Relat Res 441:291–297PubMedCrossRefGoogle Scholar
  35. Koseki H, Matsumoto T, Ito S, Doukawa H, Enomoto H, Shindo H (2005) Analysis of polyethylene particles isolated from periprosthetic tissue of loosened hip arthroplasty and comparison with radiographic appearance. J Orthop Sci 10:284–290PubMedCrossRefGoogle Scholar
  36. Kurtz SM, Gawel HA, Patel JD (2011) History and systemic review of wear and osteolysis outcomes for first-generation highly crosslinked polyethylene. Clin Orthop Relat Res 469:2262–2277PubMedCrossRefGoogle Scholar
  37. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481–1488PubMedCrossRefGoogle Scholar
  38. Lee SE, Chung WJ, Kwak HB, Chung CH, Kwak KB, Lee ZH, Kim HH (2001) Tumor necrosis factor-α supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem 276:49343–49490PubMedCrossRefGoogle Scholar
  39. Leung S, Naudie D, Kitamura N, Walde T, Engh CA (2005) Computed tomography in the assessment of periacetabular osteolysis. J Bone Joint Surg Am 87:592–597PubMedCrossRefGoogle Scholar
  40. Leung SB, Egawa H, Stepniewski A, Beykirch S, Engh CA Jr, Engh CA Sr (2007) Incidence and volume of pelvic osteolysis at early follow-up with highly cross-linked and noncross-linked polyethylene. J Arthroplasty 22:134–139PubMedCrossRefGoogle Scholar
  41. Link TM, Berning W, Scherf S, Joosten U, Joist A, Engelke K, Daldrup-Link HE (2000) CT of metal implants: reduction of artefacts using an extended CT scale technique. J Comput Assist Tomogr 24:165–172PubMedCrossRefGoogle Scholar
  42. Looney R, Boyd A, Totterman S, Seo G, Tamez-Pena J, Campbell D, Novotny L, Olcott C, Martell J, Hayes FA, O’Keefe RJ, Schwarz EM (2002) Volumetric computerized tomography as a measurement of peri-prosthetic acetabular osteolysis and its correlation with wear. Arthr Res 4:59–63CrossRefGoogle Scholar
  43. Mall NA, Nunley RM, Zhu JJ, Maloney WJ, Barrack RL, Clohisy JC (2011) The incidence of acetabular osteolysis in young patients with conventional versus highly crosslinked polyethylene. Clin Orthop Relat Res 469:372–381PubMedCrossRefGoogle Scholar
  44. Maloney WJ, Herzwurm P, Paprosky W, Rubash HE, Engh C (1997) Treatment of pelvic osteolysis associated with a stable acetabular component inserted without cement as part of a total hip replacement. J Bone Joint Surg Am 79:1628–1634PubMedGoogle Scholar
  45. McClung MR, Lewiecki EM, Geller ML, Bolognese MA, Peacock M, Weinstein RL, Ding B, Rockabrand E, Wagmar RB, Miller PD (2013) Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial. Osteoporosis Int 24:227–235CrossRefGoogle Scholar
  46. McKellop H, Shen FW, Lu B, Campbell P, Salovey R (1999) Development of an extremely wear-resistant ultra high molecular weight polyethylene for total hip replacements. J Orthop Res 17:157–167PubMedCrossRefGoogle Scholar
  47. McKellop H, Shen FW, Lu B, Campbell P, Salovey R (2000) Effect of sterilization method and other modifications on the wear resistance of acetabular cups made of ultra-high molecular weight polyethylene. J Bone Joint Surg Am 82:1708–1725PubMedGoogle Scholar
  48. Millett PJ, Allen MJ, Bostrom MP (2002) Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am 84:236–249PubMedGoogle Scholar
  49. Muratoglu OK, Bragdon CR, O’Connor DO, Jasty M, Harris WH (2001) A novel method of cross-linking ultra-high-molecular-weight polyethylene to improve wear, reduce oxidation, and retain mechanical properties. J Arthroplasty 16:149–160PubMedCrossRefGoogle Scholar
  50. Nakagawa N, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T, Higashio K (1998) RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 253:395–400PubMedCrossRefGoogle Scholar
  51. Nakashima Y, Sun DH, Maloney WJ, Goodman SB, Schurman DJ, Smith RL (1998) Induction of matrix metalloproteinase expression in human macrophages by orthopaedic particulate debris in vitro. J Bone Joint Surg Br 80:694–700PubMedCrossRefGoogle Scholar
  52. Naudie DDR, Engh CA Sr (2004) Surgical management of polyethylene wear and pelvic osteolysis with modular uncemented acetabular components. J Arthroplasty 19:124–129PubMedCrossRefGoogle Scholar
  53. Neale SD, Sabokbar A, Howie DW, Murray DW, Athanasou NA (1999) Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption. J Orthop Res 17:686–694PubMedCrossRefGoogle Scholar
  54. Neale SD, Haynes DR, Howie DW, Murray DW, Athanasou NA (2000) The effect of particle phagocytosis and metallic wear particles on osteoclast formation and bone resorption in vitro. J Arthroplasty 15:654–662PubMedCrossRefGoogle Scholar
  55. Oral E, Muratoglu OK (2011) Vitamin E diffused, highly crosslinked UHMWPE: a review. Int Orthop 35:215–223PubMedCrossRefGoogle Scholar
  56. Oral E, Christensen SD, Malhi AS, Wannomae KK, Muratoglu OK (2006) Wear resistance and mechanical properties of highly cross-linked, ultrahigh-molecular weight polyethylene doped with vitamin E. J Arthroplasty 21:580–591PubMedCrossRefGoogle Scholar
  57. Puri L, Wixson R, Stern S, Kohli J, Hendrix R, Stulberg D (2002) Use of helical computed tomography for the assessment of acetabular osteolysis after total hip arthroplasty. J Bone Joint Surg Am 84:609–614PubMedGoogle Scholar
  58. Ries MD, Pruitt L (2005) Effect of cross-linking on the microstructure and mechanical properties of ultra-high molecular weight polyethylene. Clin Orthop Relat Res 440:149–156PubMedCrossRefGoogle Scholar
  59. Sabokbar A, Fujikawa Y, Neale S, Murray DW, Athanasou NA (1997) Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis 56:414–420PubMedCrossRefGoogle Scholar
  60. Saleh KJ, Celebrezze M, Kassim R, Dykes DC, Gioe TJ, Callaghan JJ, Salvati EA (2003) Functional outcome after revision hip arthroplasty. A metaanalysis. Clin Orthop Relat Res 416:254–264PubMedCrossRefGoogle Scholar
  61. Schmalzried TP, Callaghan JJ (1999) Current concepts review. Wear in total hip and knee replacements. J Bone Joint Surg Am 81:115–136PubMedGoogle Scholar
  62. Schwarz EM, Campbell D, Totterman S, Boyd A, O’Keefe RJ, Looney RJ (2003) Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo. J Orthop Res 21:1049–1055PubMedCrossRefGoogle Scholar
  63. Stamenkov R, Howie D, Taylor J, Findlay D, McGee M, Kourlis G, Carbone A, Burwell M (2003) Measurement of bone defects adjacent to acetabular components of hip replacements. Clin Orthop Relat Res 412:117–124PubMedCrossRefGoogle Scholar
  64. Stamenkov RB, Howie DW, Neale SD, McGee MA, Taylor DJ, Findlay DM (2010) Distribution of periacetabular osteolytic lesions varies according to component design. J Arthroplasty 25:913–919PubMedCrossRefGoogle Scholar
  65. Stulberg SD, Wixson RL, Adams AD, Hendrix RW, Bernfield JB (2002) Monitoring pelvic osteolysis following total hip replacement surgery: an algorithm for surveillance. J Bone Joint Surg Am 84:116–122PubMedCrossRefGoogle Scholar
  66. Talmo CT, Shanbhag A, Rubash HE (2006) Nonsurgical management of osteolysis. Challenges and opportunities. Clin Orthop Relat Res 453:254–264PubMedCrossRefGoogle Scholar
  67. Thomas GER, Simpson DJ, Mehmood S, Taylor A, McLardy-Smith P, Gill HS, Murray DW, Glyn-Jones S (2011) The seven-year wear of highly cross-linked polyethylene in total hip arthroplasty. J Bone Joint Surg Am 93:716–722PubMedCrossRefGoogle Scholar
  68. Tower SS, Currier JH, Currier BH, Lyford KA, van Citters DW, Mayor MB (2007) Rim cracking of the cross-linked longevity polyethylene acetabular liner after total hip arthroplasty. J Bone Joint Surg Am 89:2212–2217PubMedCrossRefGoogle Scholar
  69. Ulrich-Vinther M (2007) Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Acta Orthop Suppl 78:1–64PubMedCrossRefGoogle Scholar
  70. Vernon-Roberts B, Freeman MAR (1977) The tissue response to total joint replacement prostheses. In: The scientific basis of joint replacement. Pitman Medical, London, pp 86–129Google Scholar
  71. Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, Fazzalari NL, Evdokiou A, Atkins GJ (2009) Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res 24:1434–1449PubMedCrossRefGoogle Scholar
  72. von Knoch F, Heckelei A, Wedemeyer C, Saxler G, Hilken G, Brankamp J, Sterner T, Landgraeber S, Henschke F, Loer F, von Knoch M (2005) Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. J Biomed Mater Res A 75:288–294Google Scholar
  73. Walde TA, Weiland DE, Leung SB, Kitamura N, Sychterz CJ, Engh CA Jr, Claus AM, Potter HG, Engh CA Sr (2005) Comparison of CT, MRI, and radiographs in assessing pelvic osteolysis: a cadaveric study. Clin Orthop Relat Res 437:138–144PubMedCrossRefGoogle Scholar
  74. Willert HG (1977) Reactions of the articular cartilage to wear products of artificial joint prostheses. J Biomed Mater Res 11:157–164PubMedCrossRefGoogle Scholar
  75. Xu JW, Konttinen YT, Waris V, Patiala H, Sorsa T, Santavirta S (1997) Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the prosthetic tissues in the aseptic loosening of total hip replacement (THR). Clin Rheumatol 16:244–248CrossRefGoogle Scholar
  76. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S-I, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Moringa T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclast inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597–3602PubMedCrossRefGoogle Scholar
  77. Zhang L, Jia TH, Chong AC, Bai L, Yu H, Gong W, Wooley PH, Yang SY (2010) Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model. Gene Ther 17:1262–1269PubMedCrossRefGoogle Scholar
  78. Zicat B, Engh CA, Gokcen E (1995) Patterns of osteolysis around total hip components inserted with and without cement. J Bone Joint Surg Am 77:432–439PubMedGoogle Scholar

Copyright information

© Springer Basel 2013

Authors and Affiliations

  • Donald W. Howie
    • 1
    • 2
  • Susan D. Neale
    • 1
  • David R. Haynes
    • 3
  • Oksana T. Holubowycz
    • 2
  • Margaret A. McGee
    • 1
  • Lucian B. Solomon
    • 1
    • 2
  • Stuart A. Callary
    • 1
  • Gerald J. Atkins
    • 2
  • David M. Findlay
    • 2
  1. 1.Department of Orthopaedics and TraumaRoyal Adelaide HospitalAdelaideAustralia
  2. 2.Discipline of Orthopaedics and TraumaUniversity of AdelaideAdelaideAustralia
  3. 3.Discipline of PathologyUniversity of AdelaideAdelaideAustralia

Personalised recommendations